Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- RNXT
- Price
- 1.29
- Stock movement up
- +0.06 (4.44%)
- Company name
- RenovoRx Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 31.08M
- Ent value
- 24.48M
- Price/Sales
- -
- Price/Book
- 4.40
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -4.07%
- 3 year return
- -11.05%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-05-29
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
RNXT does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 4.40 |
| EV to Sales | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 24.00M |
| EPS (TTM) | -0.37 |
| FCF per share (TTM) | -0.34 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -10.12M |
| Net income (TTM) | -9.16M |
| EPS (TTM) | -0.37 |
| EPS (1y forward) | -0.46 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 9.56M |
| Net receivables | 0.00 |
| Total current assets | 10.03M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 10.03M |
| Accounts payable | 686.00K |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 1.77M |
| Total liabilities | 2.96M |
| Shareholder's equity | 7.07M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -8.75M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -8.60M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -129.59% |
| Return on Assets | -91.35% |
| Return on Invested Capital | -129.59% |
| Cash Return on Invested Capital | -121.58% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.24 |
| Daily high | 1.33 |
| Daily low | 1.24 |
| Daily Volume | 379K |
| All-time high | 16.02 |
| 1y analyst estimate | 5.50 |
| Beta | 0.99 |
| EPS (TTM) | -0.37 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| RNXT | S&P500 | |
| Current price drop from All-time high | -91.92% | -4.11% |
| Highest price drop | -96.25% | -56.47% |
| Date of highest drop | 17 Nov 2023 | 9 Mar 2009 |
| Avg drop from high | -85.70% | -11.06% |
| Avg time to new high | 471 days | 12 days |
| Max time to new high | 940 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
31.08M
Marketcap category
Small-cap
Description
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is RenovoGem, an oncology drug-device combination product, consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company has a research collaboration with Imugene Limited to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.
Employees
8
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page